US$ 27.39
glp-1 medication competitors pharmaceutical companies Costs Explained: Managing Coverage Challenges 2025’s Breakthrough GLP-1 Obesity Treatments:
Description
Pompili M

Prescribing restrictions are likely to relax over time, and coverage and penetration improve, as increased competition and the entry of generics drive price erosion

The consistency is remarkable - each subtype is within the confidence intervals of the other

Administration officials say the average price of drugs sold on TrumpRx will start at around $350 US and then drop to $245 US over the next two years

The drugs, typically taken once weekly as injections, work by helping the pancreas increase the production of insulin to move sugar from the blood into body tissues
